May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions, LLC, announced a strategic partnership to deliver fully integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors worldwide.
The partnership combines HeartcoR's comprehensive core lab services (ECG, Cardiac Monitoring, Endpoint Adjudication) with IAG's multimodality imaging core lab expertise and DYNAMIKA technology platform, enabling an end-to-end workflow spanning cardiac safety reading, imaging acquisition, and quantitative image analysis within a unified operational and data environment.
"HeartcoR is committed to supporting our clients with comprehensive solutions, innovative tools, and high-quality scientific services," said Ciaran Cooper, chief executive officer of HeartcoR Solutions. "Partnering with Image Analysis Group allows us to offer sponsors an integrated cardiac safety and imaging solution while maintaining the independence and scientific rigor expected from specialist core labs."
"Biotech sponsors running complex oncology, cardiology, neurology and metabolic disorder trials consistently tell us they want fewer vendors, faster data access, and higher confidence in their imaging and cardiac endpoints," said Dr. Olga Kubassova, chief executive officer of Image Analysis Group (IAG). "By aligning HeartcoR's cardiac safety expertise with IAG's imaging services and DYNAMIKA platform, we are creating a true one‑stop solution that streamlines operations and supports stronger safety and efficacy narratives for regulatory submissions."
Michael Clark, chief operating officer at IAG, added: "Our CRO and pharma partners increasingly require integrated cardiac and imaging solutions. This collaboration provides access to two independent, scientifically rigorous core labs working as one, reducing operational burden and strengthening the quality and completeness of trial data."
Impact on Cardiac Clinical Trial Teams
Clinical operations and medical teams frequently source cardiac safety and imaging core lab services from separate vendors, creating fragmented data flows, delays in safety signal detection, and additional coordination burden. The IAG–HeartcoR partnership addresses these challenges by offering:
- Single point of accountability: One integrated proposal, aligned governance, and a coordinated team managing both cardiac and imaging data streams.
- Integrated data delivery: Defined integration pathways established between IAG's DYNAMIKA cloud platform for imaging data collection, management, and analysis, with HeartcoR's cardiac safety data management systems to enable seamless, auditable data flow across modalities.
- Faster, more complete safety profiles: Coordinated review of ECG and cardiac safety data alongside imaging biomarkers provides sponsors with a more holistic view of drug safety and efficacy to support interactions and submissions to global health authorities.
- Regulatory‑grade quality systems: Both organizations maintain independent GxP‑compliant quality systems, including SOPs, audit readiness and regulatory compliance frameworks aligned with FDA expectations and ICH Good Clinical Practice.
Learn more at www.ia‑grp.com and www.heartcorsolutions.com.
August 17, 2026 
